Rubin DT - Search Results

1

Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.

Torres J, Caprioli F, Katsanos KH, Lobatón T, Micic D, Zerôncio M, Van Assche G, Lee JC, Lindsay JO, Rubin DT, Panaccione R, Colombel JF. Torres J, et al. Among authors: rubin dt. J Crohns Colitis. 2016 Dec;10(12):1385-1394. doi: 10.1093/ecco-jcc/jjw116. Epub 2016 Jun 9. J Crohns Colitis. 2016. PMID: 27282402 Free PMC article.

2

The complexity and challenges of genetic counseling and testing for inflammatory bowel disease.

Cummings SA, Rubin DT. Cummings SA, et al. Among authors: rubin dt. J Genet Couns. 2006 Dec;15(6):465-76. doi: 10.1007/s10897-006-9057-0. J Genet Couns. 2006. PMID: 17106630 Review.

3

Role of antibiotics in the management of inflammatory bowel disease: a review.

Rubin DT, Kornblunth A. Rubin DT, et al. Rev Gastroenterol Disord. 2005;5 Suppl 3:S10-5. Rev Gastroenterol Disord. 2005. PMID: 17713454 Review.

4

Colorectal cancer and dysplasia in inflammatory bowel disease.

Zisman TL, Rubin DT. Zisman TL, et al. Among authors: rubin dt. World J Gastroenterol. 2008 May 7;14(17):2662-9. doi: 10.3748/wjg.14.2662. World J Gastroenterol. 2008. PMID: 18461651 Free PMC article. Review.

5

Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation.

Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Weber CR, et al. Among authors: rubin dt. Lab Invest. 2008 Oct;88(10):1110-20. doi: 10.1038/labinvest.2008.78. Epub 2008 Aug 18. Lab Invest. 2008. PMID: 18711353 Free PMC article.

6

Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.

Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, Pollack PF, Chao J, Mulani P. Loftus EV, et al. Among authors: rubin dt. Am J Gastroenterol. 2008 Dec;103(12):3132-41. doi: 10.1111/j.1572-0241.2008.02175.x. Epub 2008 Oct 3. Am J Gastroenterol. 2008. PMID: 18853973 Clinical Trial.

7

Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey.

Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, Loftus EV, Hopper J. Rubin DT, et al. Inflamm Bowel Dis. 2009 Apr;15(4):581-8. doi: 10.1002/ibd.20793. Inflamm Bowel Dis. 2009. PMID: 19067414

8

Genetic testing for inflammatory bowel disease: focus group analysis of patients and family members.

Lewis JR, Konda V, Rubin DT. Lewis JR, et al. Among authors: rubin dt. Genet Test Mol Biomarkers. 2009 Aug;13(4):495-503. doi: 10.1089/gtmb.2008.0102. Genet Test Mol Biomarkers. 2009. PMID: 19580441

9

The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.

Rubin DT, Dubinsky MC, Panaccione R, Siegel CA, Binion DG, Kane SV, Hopper J. Rubin DT, et al. Dig Dis Sci. 2010 Apr;55(4):1044-52. doi: 10.1007/s10620-009-0953-7. Epub 2009 Sep 4. Dig Dis Sci. 2010. PMID: 20155319

10

A practical, evidence-based guide to the use of adalimumab in Crohn's disease.

Rubin DT, Panaccione R, Chao J, Robinson AM. Rubin DT, et al. Curr Med Res Opin. 2011 Sep;27(9):1803-13. doi: 10.1185/03007995.2011.604672. Epub 2011 Aug 2. Curr Med Res Opin. 2011. PMID: 21809894 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

472 results

Search Page